Process and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are Correct
- 9 January 2023
- journal article
- review article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 51 (4) , 532-542
Abstract
Clearances are important parameters in pharmacokinetic (PK) models. All clearances in PK models are either process clearances that include diffusion, transport, and metabolism clearances or system clearances that include organ and systemic clearance. Clearance and volume of distribution are two independent parameters that characterize drug disposition in both individual compartments and systems of compartments. In this minireview, we show that systemic and organ clearances are net clearances that can be easily derived by partition analysis. When drugs are eliminated from the central compartment by first-order processes, systemic clearance is constant. When drugs are eliminated from a peripheral compartment, instantaneous systemic clearance will vary with time. However, average clearance and clearance at steady state will be constant and will equal dose divided by area under the curve. We show that peripheral elimination will not have a large impact on most pharmacokinetic analyses and that standard models of organ and systemic clearance are useful and appropriate. SIGNIFICANCE STATEMENT There are two basic kinds of clearances used in pharmacokinetic models, process and system clearances. We show that organ and systemic clearances are net clearances with blood or plasma as the driving concentration. For linear pharmacokinetics, clearance is constant for elimination from the central compartment but varies with time for peripheral elimination. Despite the different kinds of clearance parameters and models, standard clearance models and concepts remain valid.Keywords
This publication has 54 references indexed in Scilit:
- Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal conceptsThe AAPS Journal, 2007
- A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerationsJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1985
- History of pharmacokineticsPharmacology & Therapeutics, 1981
- Hepatic clearance of drugs. III. Additional experimental evidence supporting the “wellstirred” model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liverin situ preparationJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparationJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Enzymatic elimination of substrates flowing through the intact liverJournal of Theoretical Biology, 1976
- Volume of Distribution as a Function of TimeJournal of Pharmaceutical Sciences, 1976
- Partition analysis and concept of net rate constants as tools in enzyme kineticsBiochemistry, 1975